A decade of research and development in disability, virtual reality and associated technologies: review of ICDVRAT 1996−2006

The International Conference (series) on Disability, Virtual Reality and Associated Technologies (ICDVRAT) this year held its sixth biennial conference, celebrating ten years of research and development in this field. A total of 220 papers have been presented at the first six conferences, addressing potential, development, exploration and examination of how these technologies can be applied in disabilities research and practice. The research community is broad and multi-disciplined, comprising a variety of scientific and medical researchers, rehabilitation therapists, educators and practitioners. Likewise, technologies, their applications and target user populations are also broad, ranging from sensors positioned on real world objects to fully immersive interactive simulated environments. A common factor is the desire to identify what the technologies have to offer and how they can provide added value to existing methods of assessment, rehabilitation and support for individuals with disabilities. This paper presents a brief review of the first decade of research and development in the ICDVRAT community, defining technologies, applications and target user populations served.

Professor David Firmage, Department of Biology and Environmental Studies

Professor Emeritus David Firmage, Department of Biology and Environmental Studies. Reading Looking for Alaska by Peter Jenkins

In vivo CYP2E1 phenotyping as a new potential biomarker of occupational and experimental exposure to benzene

Assessing CYP2E1 phenotype in vivo may be important to predict individual susceptibility to those chemicals, including benzene, which are metabolically activated by this isoenzyme. Chlorzoxazone (CHZ), a specific CYP2E1 substrate, is readily hydroxylated to 6-OH-chlorzoxazone (6-OH-CHZ) by liver CYP2E1 and the metabolic ratio 6-OH-CHZ/CHZ in serum (MR) is a specific and sensitive biomarker of CYP2E1 activity in vivo in humans. We used this MR as a potential biomarker of effect in benzene-treated rats and, also, in humans occupationally exposed to low levels of benzene. Male Sprague-Dawley rats (375-400 g b.w.) were treated i.p. for 3 days with either a 0.5 ml solution of benzene (5 mmol/kg b.w.) in corn oil, or 0.5 ml corn oil alone. Twenty-four hours after the last injection, a polyethylene glycol (PEG) solution of CHZ (20 mg/kg b.w.) was injected i.p. in both treated and control animals. After 2, 5.10,15, 20,30,45, 60, 90, 120, 180, and 240 min from injection, 0.2 ml blood was taken from the tip tail and stored at -20 degrees C until analysis. A modified reverse phase HPLC method using a 5 mu m Ultrasphere C18 column equipped with a direct-connection ODS guard column, was used to measure CHZ and its metabolite 6-OH-CHZ in serum. No statistically significant difference in the MR was observed, at any sampling time, between benzene-treated and control rats. The concentration-versus-time area under the curve (AUC), however, was lower (p < 0.05, Mann-Whitney test), whereas the systemic clearance was higher (p < 0.05) in treated than in control rats. Eleven petrochemical workers occupationally exposed to low levels of airborne benzene (mean +/- SD, 25.0 +/- 24.4 mu g/m(3)) and 13 non-exposed controls from the same factory (mean +/- SD, 6.7 +/- 4.0 mu g/m(3)) signed an informed consent form and were administered 500 mg CHZ p.o. Two hours later a venous blood sample was taken for CHZ and 6-OH-CHZ measurements. Despite exposed subjects showed significantly higher levels of t,t-MA and S-PMA, two biomarkers of exposure to benzene, than non-exposed workers, no difference in the MR mean values +/- SD was found between exposed (0.59 +/- 0.29) and non-exposed (0.57 +/- 0.23) subjects. So, benzene was found to modify CHZ disposition, but not CYP2E1 phenotype in benzene-treated rats, nor in workers exposed to benzene, probably due to the levels of exposure being too low. (C) 2009 Elsevier B.V. All rights reserved.

Models of privatization and development of competition in telecommunications in Central America and Mexico

Incluye Bibliografía

Resolución 262(AC.58): Actividades de la CEPAL en materia de comercio y desarrollo = Resolution 262(AC.58): ECLA's activities in the field of trade and development = Résolution 262(AC.58): Activités de la CEPAL concernant le commerce et le développement

Incluye Bibliografía

El crecimiento de la población de América Latina y las primeras etapas de las políticas de población: su influencia sobre los problemas de la juventud y el desarrollo = Population growth and the first stages of population policy in Latin America: effect on problems of youth and development

Incluye Bibliografía

América Latina y el Caribe: dinámica de la población y desarrollo = Latin America and the Caribbean: the dynamics of population and development

Incluye Bibliografía

Department of Veterinary and Biomedical Sciences: 2000 Annual Report

Foreword, 2000 John A . Schmitz. Professor and Department Head Veterinary and Biomedical Sciences Personnel Faculty Profiles Teaching program Research program Extension Program Nebraska Veterinary and Diagnostic Laboratory Systems Grants and Contracts Funded or Active in 2000 Patents by VBMS Faculty in 2000 Publications by VBMS Faculty in 2000 Presentations by VBMS Faculty in 2000 Articles Regarding the Department in 2000 Selected Committees, Editorial and Other Appointments of VBMS Faculty Departmental Budget Summaries Nebraska Agricultural Statistics 1999

Department of Veterinary and Biomedical Sciences 2004 Annual Report

Veterinary and Biomedical Sciences Personnel VBMS Teaching Program VBMS Research Program International Activities, 2004 Veterinary Extension Program. 2004 VBMS Grants and Contracts Program. 2004 Refereed Publications by VBMS Faculty in 2004 Department of Veterinary and Biomedical Sciences. Selected Committees, Editorial and Other Appointments. 2004 Articles Regarding the Department in 2004 Departmental Budget Summaries. 2004 Nebraska Agricultural Statistics. 2003/2004